Recombinant FGFR3 (Vofatamab Biosimilar) antibody (PE)

Catalog No. ABIN7867264

The PE-conjugated Humanized Monoclonal anti-FGFR3 (Vofatamab Biosimilar) antibody (ABIN7867264) specifically detects FGFR3 (Vofatamab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant FGFR3 (Vofatamab Biosimilar) antibody (PE) (ABIN7867264)

Target: FGFR3 (Vofatamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This FGFR3 (Vofatamab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-FGFR3 (Vofatamab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-FGFR3(vofatamab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for FGFR3 (Vofatamab Biosimilar)

Target: FGFR3 (Vofatamab Biosimilar)

Alternative Name: vofatamab biosimilar

Target Type: Biosimilar

Background:

Synonyms: FGFR-3, CD333, JTK4,MFGR1877S

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: P22607